These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34431463)

  • 1. Targeting Triglyceride Metabolism for Colorectal Cancer Prevention and Therapy.
    Yarla N; Madka V; Rao C
    Curr Drug Targets; 2022; 23(6):628-635. PubMed ID: 34431463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated Analysis of Expression and Prognostic Values of Acyl-CoA Dehydrogenase short-chain in Colorectal Cancer.
    Wu Q; Yan T; Chen Y; Chang J; Jiang Y; Zhu D; Wei Y
    Int J Med Sci; 2021; 18(16):3631-3643. PubMed ID: 34790035
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro effects of active components of Polygonum Multiflorum Radix on enzymes involved in the lipid metabolism.
    Wang W; He Y; Lin P; Li Y; Sun R; Gu W; Yu J; Zhao R
    J Ethnopharmacol; 2014 May; 153(3):763-70. PubMed ID: 24680992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Targets in Precision Chemoprevention of Colorectal Cancer: An Update from Pre-Clinical to Clinical Trials.
    Yarla NS; Madka V; Pathuri G; Rao CV
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipose triglyceride lipase promotes the proliferation of colorectal cancer cells via enhancing the lipolytic pathway.
    Yin H; Li W; Mo L; Deng S; Lin W; Ma C; Luo Z; Luo C; Hong H
    J Cell Mol Med; 2021 Apr; 25(8):3963-3975. PubMed ID: 33621408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LC-MS-based lipid profile in colorectal cancer patients: TAGs are the main disturbed lipid markers of colorectal cancer progression.
    Liu T; Peng F; Yu J; Tan Z; Rao T; Chen Y; Wang Y; Liu Z; Zhou H; Peng J
    Anal Bioanal Chem; 2019 Aug; 411(20):5079-5088. PubMed ID: 31201454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of type I collagen during tumorigenesis of colorectal cancer revealed by quantitative proteomic analysis.
    Zou X; Feng B; Dong T; Yan G; Tan B; Shen H; Huang A; Zhang X; Zhang M; Yang P; Zheng M; Zhang Y
    J Proteomics; 2013 Dec; 94():473-85. PubMed ID: 24332065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty Acid Metabolism-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Patients With Colorectal Cancer.
    Peng Y; Xu C; Wen J; Zhang Y; Wang M; Liu X; Zhao K; Wang Z; Liu Y; Zhang T
    Front Oncol; 2021; 11():704038. PubMed ID: 34458145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A significant role of lipogenic enzymes in colorectal cancer.
    Notarnicola M; Messa C; Caruso MG
    Anticancer Res; 2012 Jul; 32(7):2585-90. PubMed ID: 22753716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPARCL1 Is a Novel Prognostic Biomarker and Correlates with Tumor Microenvironment in Colorectal Cancer.
    Zhang HP; Wu J; Liu ZF; Gao JW; Li SY
    Biomed Res Int; 2022; 2022():1398268. PubMed ID: 35111844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer.
    Lin D; Fan W; Zhang R; Zhao E; Li P; Zhou W; Peng J; Li L
    J Transl Med; 2021 Jun; 19(1):279. PubMed ID: 34193202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting PLA2G16, a lipid metabolism gene, by Ginsenoside Compound K to suppress the malignant progression of colorectal cancer.
    Yang L; Zheng L; Xie X; Luo J; Yu J; Zhang L; Meng W; Zhou Y; Chen L; Ouyang D; Zhou H; Tan Z
    J Adv Res; 2022 Feb; 36():265-276. PubMed ID: 35127176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer.
    Gao X; Yang J
    DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipidome in colorectal cancer.
    Yan G; Li L; Zhu B; Li Y
    Oncotarget; 2016 May; 7(22):33429-39. PubMed ID: 26967051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision Nutrition for Targeting Lipid Metabolism in Colorectal Cancer.
    Aguirre-Portolés C; Fernández LP; Ramírez de Molina A
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28956850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
    Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
    Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Pathways Regulating Colorectal Cancer: A Potential Therapeutic Approach.
    Zafari N; Velayati M; Damavandi S; Pourali G; Mobarhan MG; Nassiri M; Hassanian SM; Khazaei M; Ferns GA; Avan A
    Curr Pharm Des; 2022; 28(36):2995-3009. PubMed ID: 36154599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated Profiling Identifies
    Shi J; Bao M; Wang W; Wu X; Li Y; Zhao C; Liu W
    Front Immunol; 2021; 12():722807. PubMed ID: 34646265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of dysregulated lncRNAs profiling and metastasis-associated lncRNAs in colorectal cancer by genome-wide analysis.
    Chen Y; Yu X; Xu Y; Shen H
    Cancer Med; 2017 Oct; 6(10):2321-2330. PubMed ID: 28857495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNNT2 as a potential biomarker for the progression and prognosis of colorectal cancer.
    Jing L; Feng L; Zhou Z; Shi S; Deng R; Wang Z; Zhang Y; Ren Z; Liu Y
    Oncol Rep; 2020 Aug; 44(2):628-636. PubMed ID: 32627044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.